Otonomy to Report Third Quarter 2016 Financial Results and Provide Corporate Update

Webcast and Conference Call to be Held at 4:30 p.m. EDT on November 3, 2016 SAN DIEGO , Oct. 27, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear,

Apply Now